Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Daniel W Muehl. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Daniel W Muehl reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:CLVS / Clovis Oncology Inc See Remarks 104,830
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Daniel W Muehl. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Daniel W Muehl conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,066 104,830 -1.93 0.98 -2,031 103,048
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,513 102,271 -2.40 0.98 -2,470 100,532
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 106,896 4.52
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,623 104,784 5.67
2022-09-06 2022-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,234 99,161 -2.20 1.20 -2,681 118,993
2022-09-06 2022-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,063 101,395 5.26
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,100 96,332 -2.13 1.46 -3,068 140,731
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,554 93,807 -2.65 1.46 -3,731 137,043
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 98,432 4.93
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,624 96,361 6.20
2022-06-03 2022-06-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,327 90,737 -2.50 0.64 -1,495 58,289
2022-06-03 2022-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,062 93,064 5.75
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,062 88,002 -2.29 1.97 -4,062 173,346
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,508 85,439 -2.85 1.97 -4,940 168,298
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 32,375 -12.50
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5,623 16,871 -25.00
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 90,064 5.41
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,623 87,947 6.83
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -10,416 82,324 -11.23 1.87 -19,436 153,617
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -290 72,490 -0.40 1.87 -541 135,266
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 563 0 -100.00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 20,250 60,750 50.00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81,000 81,000
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 20,250 92,740 27.93
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 72,780 0.78
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,453 72,217 -3.29 1.94 -4,758 140,072
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,983 70,045 -4.08 1.94 -5,786 135,866
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 37,000 -11.11
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5,625 22,494 -20.00
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 74,670 6.60
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,625 73,028 8.35
2021-12-03 2021-12-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -248 67,403 -0.37 3.00 -744 202,209
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -562 563 -49.96
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 67,651 0.84
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,041 67,089 -2.95 4.55 -9,287 305,255
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,482 64,505 -3.71 4.55 -11,293 293,498
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 41,625 -10.00
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5,623 28,119 -16.66
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 69,130 7.17
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,623 66,987 9.16
2021-09-03 2021-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -249 61,364 -0.40 4.89 -1,218 300,070
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -563 1,125 -33.35
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 61,613 0.92
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,034 61,050 -3.22 4.82 -9,804 294,261
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,473 58,459 -4.06 4.82 -11,920 281,772
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 46,250 -9.09
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5,624 33,743 -14.29
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 63,084 7.91
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,624 60,932 10.17
2021-06-03 2021-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -231 55,308 -0.42 5.63 -1,301 311,384
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 562 1,688 49.91
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 55,539 1.02
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,448 54,977 -2.57 5.54 -8,022 304,573
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,206 53,358 -2.21 5.54 -6,681 295,603
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,183 52,008 -4.03 5.54 -12,094 288,124
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 50,875 -8.33
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5,623 39,367 -12.50
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,067 56,425 5.75
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,556 54,564 4.91
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 54,191 9.33
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 47,815 1.19
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 47,459 1.00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 563 2,250 33.37
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 469 0 -100.00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81,000 81,000
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -249 47,566 -0.52 6.29 -1,566 299,190
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -207 47,252 -0.44 6.29 -1,302 297,215
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -9,254 46,990 -16.45 7.97 -73,754 374,510
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,187 37,744 -3.05 7.97 -9,460 300,820
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,431 36,374 -3.79 7.97 -11,405 289,901
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -18,500 55,500 -25.00
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5,625 44,990 -11.11
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 18,500 56,244 49.01
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,557 38,931 7.03
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,068 37,805 8.83
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -562 2,813 -16.65
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 469 -50.00
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -249 34,737 -0.71 4.89 -1,218 169,864
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 34,986 1.63
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -208 34,424 -0.60 4.89 -1,017 168,333
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 34,632 1.37
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5,623 50,615 -10.00
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,382 34,163 -3.89 4.93 -6,813 168,424
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,067 35,545 9.44
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,152 32,478 -3.43 4.93 -5,679 160,117
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,556 33,630 8.23
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -563 3,375 -14.30
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 938 -33.33
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -237 31,074 -0.76 5.30 -1,256 164,692
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 31,311 1.83
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -198 30,748 -0.64 5.30 -1,049 162,964
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 30,946 1.54
2020-08-27 2020-08-26 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -547 0 -100.00
2020-08-27 2020-08-26 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -242 30,477 -0.79 5.07 -1,227 154,518
2020-08-27 2020-08-26 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 547 30,719 1.81
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5,624 56,238 -9.09
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,367 30,172 -4.33 5.92 -8,093 178,618
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,068 31,539 10.78
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,139 28,471 -3.85 5.92 -6,743 168,548
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,556 29,610 9.45
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -562 3,938 -12.49
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -468 1,407 -24.96
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -256 27,054 -0.94 7.03 -1,800 190,190
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 27,310 2.10
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -214 26,748 -0.79 7.03 -1,504 188,038
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 468 26,962 1.77
2020-05-28 2020-05-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -547 547 -50.00
2020-05-28 2020-05-27 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -247 26,494 -0.92 6.91 -1,707 183,074
2020-05-28 2020-05-27 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 547 26,741 2.09
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -5,623 61,862 -8.33
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,207 26,194 -4.40 8.10 -9,777 212,171
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,067 27,401 12.60
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,006 24,334 -3.97 8.10 -8,149 197,105
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,556 25,340 11.22
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -563 4,500 -11.12
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 1,875 -20.01
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -259 22,784 -1.12 7.20 -1,865 164,045
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 23,043 2.50
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -216 22,480 -0.95 7.20 -1,555 161,856
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 22,696 2.11
2020-03-02 2020-02-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -547 1,094 -33.33
2020-03-02 2020-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -279 22,227 -1.24 6.90 -1,925 153,366
2020-03-02 2020-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 547 22,506 2.49
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -22,497 67,485 -25.00
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -5,429 21,959 -19.82 8.41 -45,658 184,675
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 12,271 27,388 81.17
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -5,043 15,117 -25.01 8.41 -42,412 127,134
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 10,226 20,160 102.94
2020-01-31 2020-01-31 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 74,000 74,000
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -562 5,063 -9.99
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 2,344 -16.67
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -254 9,934 -2.49 14.59 -3,706 144,937
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 10,188 5.84
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -212 9,626 -2.15 14.59 -3,093 140,443
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 9,838 5.01
2019-11-29 2019-11-26 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -546 1,641 -24.97
2019-11-29 2019-11-26 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -242 9,369 -2.52 10.20 -2,468 95,564
2019-11-29 2019-11-26 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 546 9,611 6.02
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -563 5,625 -9.10
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 2,813 -14.29
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -270 9,065 -2.89 5.21 -1,407 47,229
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 563 9,335 6.42
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -225 8,772 -2.50 5.21 -1,172 45,702
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 8,997 5.50
2019-08-28 2019-08-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -547 2,187 -20.01
2019-08-28 2019-08-27 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -239 8,528 -2.73 6.09 -1,456 51,936
2019-08-28 2019-08-27 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 547 8,767 6.65
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -562 6,188 -8.33
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -468 3,282 -12.48
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -247 8,220 -2.92 15.07 -3,722 123,875
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 562 8,467 7.11
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -206 7,905 -2.54 15.07 -3,104 119,128
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 468 8,111 6.12
2019-05-31 2019-05-29 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -547 2,734 -16.67
2019-05-31 2019-05-29 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -271 7,643 -3.42 14.88 -4,032 113,728
2019-05-31 2019-05-29 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 547 7,914 7.43
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2,250 6,750 -25.00
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 3,750 -11.12
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,060 7,367 -12.58 29.29 -31,047 215,779
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,250 8,427 36.43
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -237 6,177 -3.70 29.29 -6,942 180,924
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 6,414 7.89
2019-02-28 2019-02-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -547 3,281 -14.29
2019-02-28 2019-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -266 5,945 -4.28 25.90 -6,889 153,976
2019-02-28 2019-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 547 6,211 9.66
2019-02-06 2019-02-01 4/A CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 89,982 89,982
2019-02-06 2019-02-01 4/A CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 29,994 29,994
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 59,988 59,988
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 19,996 19,996
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 4,219 -10.00
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -188 5,664 -3.21 21.23 -3,991 120,247
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 5,852 8.71
2018-11-28 2018-11-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -546 3,828 -12.48
2018-11-28 2018-11-27 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -237 5,383 -4.22 16.62 -3,939 89,465
2018-11-28 2018-11-27 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 546 5,620 10.76
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -469 4,688 -9.09
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -212 5,074 -4.01 35.75 -7,579 181,396
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 469 5,286 9.74
2018-08-28 2018-08-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -547 4,374 -11.12
2018-08-28 2018-08-27 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -242 4,817 -4.78 35.15 -8,506 169,318
2018-08-28 2018-08-27 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 547 5,059 12.12
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -468 5,157 -8.32
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -208 4,512 -4.41 47.70 -9,922 215,222
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 468 4,720 11.01
2018-06-01 2018-05-31 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -547 4,921 -10.00
2018-06-01 2018-05-31 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -248 4,252 -5.51 48.63 -12,060 206,775
2018-06-01 2018-05-31 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 547 4,500 13.84
2018-03-09 2018-03-07 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 5,625 -25.00
2018-03-09 2018-03-07 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -826 3,953 -17.28 58.43 -48,263 230,974
2018-03-09 2018-03-07 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 4,779 64.57
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -547 5,468 -9.09
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -259 2,904 -8.19 55.51 -14,377 161,201
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 547 3,163 20.91
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 9,000 9,000
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 9,000 9,000
2017-12-01 2017-11-29 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -547 6,015 -8.34
2017-12-01 2017-11-29 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -259 2,616 -9.01 59.49 -15,408 155,626
2017-12-01 2017-11-29 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 547 2,875 23.50
2017-09-01 2017-08-29 4/A CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -710 2,328 -23.37 72.14 -51,219 167,942
2017-08-29 2017-08-25 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2,188 6,562 -25.01
2017-08-29 2017-08-25 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -700 2,338 -23.04 73.16 -51,212 171,048
2017-08-29 2017-08-25 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,188 3,038 257.41
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 7,500 7,500
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2017-03-08 2017-03-08 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,250 1,250 -50.00
2017-03-08 2017-03-08 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -400 850 -32.00 59.27 -23,708 50,380
2017-03-08 2017-03-08 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,250 1,250
2016-08-29 2016-08-25 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 8,750 8,750
2016-08-29 2016-08-25 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 37,500 37,500
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)